<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical and haematological features of 13 patients with secondary <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) were studied, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> developed subsequent to chemotherapy and/or radiotherapy for various haematological or non-haematological diseases </plain></SENT>
<SENT sid="1" pm="."><plain>In six cases, the first sign was a persistently increased mean cell volume (MCV) and a <z:mp ids='MP_0000248'>macrocytosis</z:mp> preceding from 6 to 18 months the appearance of severe <z:hpo ids='HP_0001903'>anaemia</z:hpo> or <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>In five cases, the initial finding was a macrocytic <z:hpo ids='HP_0001903'>anaemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">Dysmyelopoiesis</z:e> was a constant and prominent feature of the bone marrow smears at some time during the course of the disease </plain></SENT>
<SENT sid="4" pm="."><plain>Two cases without <z:mp ids='MP_0000248'>macrocytosis</z:mp> at any time directly developed overt <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
</text></document>